ATRA

Atara Biotherapeutics Stock Analysis

AI Rating

Neutral
  • Quality4/10
  • Growth↑ 8/10
  • Value↓ 0/10
Atara Biotherapeutics sales and earnings growth
ATRA Growth
Good
  • Revenue Y/Y↓ -91.70%
  • EPS Y/Y↑ 70.43%
  • FCF Y/Y↑ 63.00%
Atara Biotherapeutics gross and profit margin trends
ATRA Profitability
Fair
  • Gross margin ↑ 96.10%
  • EPS margin↓ -40.90%
  • ROIC 5Y↓ -137.92%
Atara Biotherapeutics net debt vs free cash flow
ATRA Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 1.7
  • Interest coverage↓ -1.6

Atara Biotherapeutics stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks